Emily Bavasi is a Seattle, Washington based nurse practitioner. Active license number of Emily Bavasi is AP61351969 for Obstetrics & Gynecology in Washington. Her current practice location is 858 Nw 90th St, Seattle. Patients can reach her at 206-419-4063 and her NPI number (Unique professional ID assigned by NPPES) is 1073189817. Emily Bavasi has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Emily Bavasi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1073189817
NPI Enumeration Date:
02 Jun, 2021
NPI Last Update On:
03 Jan, 2024
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Bavasi are as mentioned below.
License Number
Specialization
State
Status
AP61351969
Obstetrics & Gynecology
Washington
Primary
RN60282751
Registered Nurse
Washington
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Emily Bavasi 900 Pacific Ave Ste 501, Everett, Washington
Zip:
98201-4189
Phone Number:
425-303-6500
Patients can reach Emily Bavasi at 858 Nw 90th St, Seattle, Washington or can call to book an appointment on 206-419-4063.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.